1. Home
  2. SG vs ADPT Comparison

SG vs ADPT Comparison

Compare SG & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SG
  • ADPT
  • Stock Information
  • Founded
  • SG 2007
  • ADPT 2009
  • Country
  • SG United States
  • ADPT United States
  • Employees
  • SG N/A
  • ADPT N/A
  • Industry
  • SG Restaurants
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SG Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • SG Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • SG 1.8B
  • ADPT 1.8B
  • IPO Year
  • SG 2021
  • ADPT 2019
  • Fundamental
  • Price
  • SG $8.49
  • ADPT $12.61
  • Analyst Decision
  • SG Buy
  • ADPT Strong Buy
  • Analyst Count
  • SG 15
  • ADPT 8
  • Target Price
  • SG $18.36
  • ADPT $12.38
  • AVG Volume (30 Days)
  • SG 5.7M
  • ADPT 1.8M
  • Earning Date
  • SG 11-06-2025
  • ADPT 11-06-2025
  • Dividend Yield
  • SG N/A
  • ADPT N/A
  • EPS Growth
  • SG N/A
  • ADPT N/A
  • EPS
  • SG N/A
  • ADPT N/A
  • Revenue
  • SG $686,222,000.00
  • ADPT $205,216,000.00
  • Revenue This Year
  • SG $8.56
  • ADPT $32.76
  • Revenue Next Year
  • SG $18.75
  • ADPT $15.81
  • P/E Ratio
  • SG N/A
  • ADPT N/A
  • Revenue Growth
  • SG 5.74
  • ADPT 21.60
  • 52 Week Low
  • SG $8.11
  • ADPT $3.98
  • 52 Week High
  • SG $45.12
  • ADPT $13.68
  • Technical
  • Relative Strength Index (RSI)
  • SG 35.14
  • ADPT 51.14
  • Support Level
  • SG $8.11
  • ADPT $12.34
  • Resistance Level
  • SG $9.05
  • ADPT $13.68
  • Average True Range (ATR)
  • SG 0.37
  • ADPT 0.56
  • MACD
  • SG 0.12
  • ADPT -0.08
  • Stochastic Oscillator
  • SG 28.57
  • ADPT 20.15

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: